Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016278
Filing Date
2023-05-11
Accepted
2023-05-11 07:30:55
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 732959
2 ex31-1.htm EX-31.1 15691
3 ex31-2.htm EX-31.2 15520
4 ex32.htm EX-32 12262
  Complete submission text file 0001493152-23-016278.txt   4765970

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20230331.xsd EX-101.SCH 33275
6 XBRL CALCULATION FILE abeo-20230331_cal.xml EX-101.CAL 59133
7 XBRL DEFINITION FILE abeo-20230331_def.xml EX-101.DEF 171542
8 XBRL LABEL FILE abeo-20230331_lab.xml EX-101.LAB 331460
9 XBRL PRESENTATION FILE abeo-20230331_pre.xml EX-101.PRE 265424
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 693150
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 23908838
SIC: 2834 Pharmaceutical Preparations